| Ekta Gupta, MD | |
|
10700 Charter Dr Ste 310, Columbia, MD 21044-3730 | |
| (443) 546-1512 | |
| (410) 715-0370 |
| Full Name | Ekta Gupta |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 20 Years |
| Location | 10700 Charter Dr Ste 310, Columbia, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902099336 | NPI | - | NPPES |
| 033194500 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | MD039304 (Maryland) | Primary |
| 208M00000X | Hospitalist | D70609 (Maryland) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Johns Hopkins Hospital, The | Baltimore, MD | Hospital |
| Johns Hopkins Bayview Medical Center | Baltimore, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johns Hopkins University | 8921903147 | 2692 |
News Archive
University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.
Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.
› Verified 9 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.
Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.
› Verified 9 days ago
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1902332133 PECOS PAC ID: 4981745098 Enrollment ID: O20170818000085 |
News Archive
University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.
Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ekta Gupta, MD 10700 Charter Dr Ste 310, Columbia, MD 21044-3730 Ph: (443) 546-1512 | Ekta Gupta, MD 10700 Charter Dr Ste 310, Columbia, MD 21044-3730 Ph: (443) 546-1512 |
News Archive
University of Utah researchers have discovered a new class of compounds that stick to the sugary coating of the AIDS virus and inhibit it from infecting cells - an early step toward a new treatment to prevent sexual transmission of the virus.
Researchers showed that 20-50% of patients developed an irregular heartbeat that required defibrillation during the active cooling phase of therapeutic hypothermia following an out-of-hospital cardiac arrest.
Foundation Medicine today announced new data from a pilot study demonstrating that its fully informative genomic profile for hematologic malignancies, FoundationOne Heme, identified both novel and previously reported clinically actionable genomic alterations in multiple myeloma cases. These data were presented in an oral presentation titled Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma (abstract number 755) by Alexander Lesokhin, M.D., medical oncologist, Memorial Sloan-Kettering Cancer Center, at the 55th American Society of Hematology Annual Meeting in New Orleans.
Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association's 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain's response to food, possibly reducing cravings and increasing satisfaction while eating.
› Verified 9 days ago
Dr. Jon Kent Minford, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380 | |
Dr. Jacob Cherian, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Columbia, MD 21045 Phone: 410-964-5311 Fax: 410-964-8578 | |
Dr. Tejaswi Rajasekhara Sastry, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite G020, Columbia, MD 21044 Phone: 410-964-2212 Fax: 410-964-0380 | |
Michael Howard Kelemen, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5450 Knoll North Dr, Suite 200b, Columbia, MD 21045 Phone: 410-964-5303 | |
Dr. Tin O Maung, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5999 Harpers Farm Rd, Suite W250, Columbia, MD 21044 Phone: 410-772-8822 Fax: 410-772-9274 | |
Dr. Jeffery Wayne Van Den Broek, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 10710 Charter Dr, Suite 110, Columbia, MD 21044 Phone: 410-992-9797 Fax: 410-730-0942 | |
Angela M. Kopack, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 11055 Little Patuxent Pkwy, Suite 209, Columbia, MD 21044 Phone: 410-884-1311 Fax: 410-884-6033 |